Ishita Drugs & Indus Quarterly Results for Trading Insights
ISHITADR • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1 Cr
QMarch 2025
Ishita Drugs & Indus Quarterly Results Key Highlights
- Revenue of ₹15 Cr in March 2025 (+0.0% vs March 2025, -6.2% vs March 2024)
- Net Profit of ₹1 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
- EBITDA of ₹1 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 7.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹2.90 in March 2025 (+0.0% vs March 2025)
Ishita Drugs & Indus Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 18 | 15 | 16 | 12 | 14 | 20.0% | - |
| Net Profit (₹ Cr) | 1 | 1 | 1 | 1 | 1 | - | - |
| EBITDA (₹ Cr) | 2 | 1 | 1 | 1 | 1 | - | - |
| EPS (₹) | 3.20 | 2.90 | 2.50 | 1.93 | 2.69 | - | - |
| Operating Margin (%) | 7.0% | 7.0% | 6.0% | 6.0% | 8.0% | - | - |
Ishita Drugs & Indus Share Price Trend Around Quarterly Results
Visualize Ishita Drugs & Indus's 1-year price movement across quarterly results — ideal for logging trades in Ishita Drugs & Indus share price
chart using Tickjournal. All values in ₹.
Related Pages for Ishita Drugs & Indus
Additional stock information and data for ISHITADR
Revenue Trend (₹ Cr)
March 2023
12
March 2024
16
March 2025
15
2026
18
Net Profit Trend (₹ Cr)
March 2023
1
March 2024
1
March 2025
1
2026
1
Operating Margin Trend (%)
March 2023
6.0%
March 2024
6.0%
March 2025
7.0%
2026
7.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Ishita Drugs & Indus quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹438,094.57 Cr | 1825.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 140.5 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6352.5 | 2,860 | 689 | +7.1% | - | 24.1% | 244.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4431.2 | 3,219 | 591 | +11.3% | - | 18.4% | 252.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹110,630.25 Cr | 1325.5 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.9 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1329.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.5 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores